Abstract
Introduction
Life expectancy of human increases in recent century but yet many advanced diseases peril the people life, such that annually incidence rates of cancer patients increases. For example, in 2003 more than 40% dead in Europe
Methodology
DNA microarray is capable of detecting the expression levels of thousand genes over a few samples simultaneously. Therefore statistical analysis of this data is very difficult or impossible. Fortunately, this complexity and difficulty can be avoided by selection and extraction a new data matrix that contains maximal information about the classes from the original data [27] . In fact, the selection of genes that are really indicative of the tissue classification is becoming one of the key steps in microarray studies [8] . Gene selection can reduce complexity and time in the analysis of data expression and also provide a better biological interpretation of relationship between the genes.
One of the applicable methods to gene selection is the weighted voting algorithm that introduced by Ramaswamy that used to calculate the difference between huge variable data [28] . This algorithm calculates S x value for each genes of data set according to following equation.
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S x is weighted voting value for every gene, μ is the mean of expression values in class 1 and class 2 and σ is standard deviation of expression values in class 1 and class 2 [29] . The S x value show how much is correlation of each genes with particular distinction. Therefore, the weighted voting algorithm is very useful method for
Dataset
There are lots of data sets for different cancer on the National Center for Biotechnology Information (NCBI) web site: http://www.ncbi.nlm.nih.gov/geo/. We chosen a data matrix contain 84 samples with 15,923 probesets (variables) that each probeset contains one gene and it's also possible that one gene occupies more than one probeset. These samples include domestic and wide type Eker rats that some of them were treated with OTA and AA that dissolved in 0.1 M sodium bicarbonate and a few number of the samples as blank, treated with only 0.1 M sodium bicarbonate every day. Then genome data were obtained subsequently 1, 3, 7, and 14 days after treatment [23] .
Results and Discussion
The confirmation method is based on three criteria: discrimination between domestic and wild Eker rats without any treatment (blank) as "criterion one", the blank domestic Eker and their treated ones with OTA and AA as "criterion two" and the blank wild Eker and their treated ones with OTA and AA as "criterion three". A total of 84 samples were considered in this work (Figure 1) . In order to discriminate between blank domestic and wild Eker we analyzed the expression pattern of approximately 15,923 probesets in 36 samples. This data set was divided into two sets of training (24 samples) and monitoring (12 samples). The monitoring set was chosen randomly in such a way that there is adequate representative of the training set. The training set was used to develop the model. Together with the performance of the training set the performance of independent set must also monitored (monitoring set). A training set consisting of samples of known classes (e.g., domestic Eker and wild Eker) is used to select the valuable genes with high impact as biomarker by WVA that allow the most accurate discrimination of the sample in training set. There are many methods for performing the classification task. We used PLSDA and SVM which have been proved to be very useful and robust to classify the microarray gene expression data. Once these methods are trained on the optimal set of variables, it is then applied to an independent monitoring set to validate its prediction accuracy. Sixty probesets with lowest and sixty probe set with highest value of S x were selected as biomarkers is listed in Table S1 . Modeling by PLSDA method was done on diminished training set and monitoring set. Among different preprocessing methods, normalization is the best one. In Figure 2 , the result for two latent variable WVA-PLSDA model is shown. This figure shows that WVA-PLSDA method can separate two groups completely. In this figure samples separated into two regions A and B, which region A that is centralized is wild Eker rat and region B that is scattered is domestic Eker rat.
For each type of other criteria, the same procedures were applied. Sixty Biomarkers for discrimination between blank domestic Eker and treated one and blank wild Eker and treated one are listed in Table 1 and Table  2 , respectively.
Results of WVA-PLSDA modelling for criterion two and three are shown in Figure 3 and Figure 4 , respectively. Figure 3 shows three different distinct regions that indicated with A, B and C. Region A related to blank domestic samples, while samples in region B are representative of domestic Eker rats that treated with AA and region C indicates samples treated with OTA. Region B of a score plot shows the effect of the different days after treatment. Samples after first day treating with AA are distinguishable on the second latent variable from the last day treating. It's obvious there is a meaningful trend in region B. Samples move bottom up with an increase of the day after treating with AA. Also for SVM analysis we used same criteria that already have used in PLSDA analysis. In SVM only support vectors are needed for classification purpose. This means that for the classification a limited number of data points are used and therefore the calculation process would be reduced. In the present work, among 84, 48 and 36 samples of the training sets for each three criterion, only a total of 6, 8 and 6 samples were chosen as support vectors, respectively. SVM can separate a given set of binary labelled training data with a hyper-plan that is maximally distant from them. For the case in which no linear separation is possible, they can work in combination with the technique of kernels, which automatically realize a nonlinear mapping to a feature space. Generally, the hyper-plan founded by SVM in a feature space corresponds to a nonlinear decision boundary in the original space. Polynomial kernel SVM results show the 100% accuracy on training and monitoring set for each three criterion.
Results show the obtained genes by WVA are approximately in good agreement with other studies [30] - [32] . Tsc1 (Tuberous sclerosis protein 1) is a human protein and gene. This peripheral membrane protein was implicated as a tumour suppressor. Defects in this gene may cause tuberous sclerosis, due to a functional impairment of the hamartin-tuberin complex. In some articles reported that Tsc1 gene mutations are involved in renal cancer carcinogenesis [33] - [35] . Ghr (Growth hormone receptor) is gene title that encoded for protein that is a transmembrane receptor for growth hormone and some investigations confirmed relation between defect in this gene and renal cancer [36] [37] . Keap1 is code name for Kelch-like ECH-associated protein 1. Series of synthetic oleane triterpenoid compounds, known as antioxidant inflammation modulators (AIMs), are being developed by Reata Pharmaceuticals, Inc. and are potent inducers of the Keap1-Nrf2 pathway, blocking Keap1-dependent Nrf2 ubiquitination and leading to the stabilization and nuclear translocation of Nrf2 and subsequent induction of Nrf2 target genes.
Different types of genes with unknown function among the "top 120" deserve high superiority in future studies that provide shortcuts in genome-based renal cancer research.
Conclusion
In this research, we presented WVA, PLSDA and SVM for feature selection and classification of two type rats treated with AA and OTA drugs, based on microarray gene expression data. The methodology involves dimension reduction of high-dimensional gene expression data, followed by feature selection using WVA and classification by applying PLSDA and SVM. The results show that these methods are effective and efficient in classifying renal cancer.
Supporting Information
The structure of Arisitolochic Acid (AA) and Ochratoxin A (OTA) available in the supporting information. In 8 September 2014 | Volume 1 | e859 addition, gene selected from weighted voting algorithm of blank Eker rats given in Table S1 .
